Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display

3971 - An advanced tumor shape radiomic signature predicts recurrence of locally advanced (LA) HNSCC patients (pts)


09 Oct 2016


Poster display


Elaine Johanna Limkin


Annals of Oncology (2016) 27 (6): 328-350. 10.1093/annonc/mdw376


E.J.C. Limkin, A. Schernberg, S. Reuze, L. Behar, D. Ou, Y.G. Tao, E. Deutsch, C. Robert, C. Ferte

Author affiliations

  • Radiation Oncology, Institut Gustave Roussy, 94805 - Villejuif/FR


Abstract 3971


Radiomics delivers multifaceted tumor characterization with complex quantitative features extraction from medical imaging related with prognostic clinical outcomes in cancer decision support. Distinct from texture and histogram analysis, advanced 2D and 3D shape parameters could reflect tumor local invasion and outcome as well as histological invasion patterns in LA HNSCC pts.


Tumor contours were defined from semi-automatic delineation of baseline contrast-enhanced CT scan. We trained a radiomic signature made of 27 complex parameters reflecting tumor convolution and shape complexity from 120 LA HNSCC pts retrospectively evaluated at Gustave Roussy Institute. We validated this particular shape signature on 86 LA HNSCC pts from TCGA database with assessable pre-treatment CT. Theses 3D silhouette parameters (n = 27) comprised fraction of convex on concave edges, distance to arithmetic mean average position, and Minkowski dimension. We connected it to PFS, OS, and outcome events. Concordance Index (CI) and Kaplan Meier estimations assessed our signature's competence. Unsupervised bi-clustering methods linked radiomics features and clinical endpoints.


We successively trained a powerful shape signature based on 9 complex parameters in these populations, significant through OS, PFS and local control predictions. Combining our shape radiomic signature with clinical factors (age, tumor location …) significantly improved results over clinical evaluation alone. Particularly, an unsupervised analysis of radiomics shape factors alone linked with tumor location (p 


We created a shape-based radiomic signature presenting a potential prediction of invasive histological characters, correlated recurrence and prognosis in LA HNSCC pts, independently from TNM stage, tumor location, surgery, chemoradiation or further treatment, which could change the initial treatment plan for LA HNSCC pts and improve patient stratification.

Clinical trial identification

Legal entity responsible for the study





All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings